Windsor Creek Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Windsor Creek Advisors’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-20,478	Closed	-$1.27M	–	179
2020 Q4	$1.27M	Buy	20,478 +10,658	+109%	+$655K	0.32%	75
2020 Q3	$592K	Sell	9,820 -23,570	-71%	-$1.42M	0.17%	103
2020 Q2	$1.96M	Buy	+33,390	New	+$2M	0.65%	34
2019 Q3	–	Sell	-17,000	Closed	-$771K	–	159
2019 Q2	$771K	Sell	17,000 -11,337	-40%	-$528K	0.21%	81
2019 Q1	$1.35M	Buy	+28,337	New	+$1.41M	0.36%	70

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Windsor Creek Advisors's BMY Position: Q1 2021 in Review

Windsor Creek Advisors sold out of Bristol-Myers Squibb (BMY) in Q1 2021, closing a stake of 20,478 shares — an estimated $1.27M sold.

Windsor Creek Advisors first reported a position in BMY in Q1 2019 and held it in 5 quarters. The position peaked at $1.96M in Q2 2020. 2,368 funds tracked by Wall St. Rank hold BMY as of Q1 2021.

Windsor Creek Advisors reported no remaining Bristol-Myers Squibb position as of Q1 2021 after selling out during the quarter.
Windsor Creek Advisors sold 20,478 Bristol-Myers Squibb shares in Q1 2021, an estimated $1.27M.
Windsor Creek Advisors first reported a position in Bristol-Myers Squibb in Q1 2019 and held it in 5 quarters.
Windsor Creek Advisors's Bristol-Myers Squibb position peaked at $1.96M in Q2 2020.
2,368 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2021.

Based on Windsor Creek Advisors's 13F filing for Q1 2021, filed 13 May 2021.